SomaLogic Q3 EPS $(0.12) Beats $(0.17) Estimate, Sales $22.05M Beat $20.47M Estimate
Portfolio Pulse from bharat@benzinga.com
SomaLogic (NASDAQ:SLGC) reported Q3 losses of $(0.12) per share, beating the analyst consensus estimate of $(0.17) by 29.41%. This is a 33.33% increase over losses from the same period last year. The company also reported quarterly sales of $22.05M, beating the analyst consensus estimate of $20.47M by 7.71%. However, this is a 47.14% decrease over sales from the same period last year.
November 08, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
SomaLogic's Q3 results beat analyst estimates for both EPS and sales. However, sales have decreased significantly compared to the same period last year.
While SomaLogic's Q3 results beat analyst estimates, which is generally positive for the stock, the significant decrease in sales compared to the same period last year could be a concern for investors. This mixed result makes the short-term impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100